Ajulemic acid: potential treatment for chronic inflammation
Abstract Ajulemic acid (AJA, CT‐3, IP‐751, JBT‐101, anabasum) is a first‐in‐class, synthetic, orally active, cannabinoid‐derived drug that preferentially binds to…
Abstract Ajulemic acid (AJA, CT‐3, IP‐751, JBT‐101, anabasum) is a first‐in‐class, synthetic, orally active, cannabinoid‐derived drug that preferentially binds to…
Abstract Background and Objectives: Opioid use disorder (OUD) is a chronic condition with potentially severe health and social consequences. Many…
Abstract A substantial body of credible evidence has accumulated that suggest that cannabis use is an important potentially preventable risk…
Abstract Chronic pain is an important health and social problem. Misuse and abuse of opioids in chronic non-cancer pain management…
Abstract Endogenous and exogenous cannabinoids bind to central cannabinoid receptors to control a multitude of behavioral functions, including aggression. The…
Abstract Mycobacterium marinum is an opportunistic pathogen inducing infection in fresh and marine water fish. This pathogen causes necrotizing granuloma…
Abstract Investigating the pharmacology is key to the modernization of Chinese Medicine (CM) formulas. However, identifying which are the active…
Abstract Cannabis is the most commonly used substance of abuse in the United States after alcohol and tobacco. With a…
Abstract In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia,…
Abstract The biological effects of cannabinoids, the major constituents of the ancient medicinal plant Cannabis sativa (marijuana) are mediated by…